Neo Ivy Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MillerKnoll
MLKN
|
+$754K |
| 2 |
Lennar Class A
LEN
|
+$740K |
| 3 |
Hexcel
HXL
|
+$733K |
| 4 |
Cinemark Holdings
CNK
|
+$732K |
| 5 |
First American
FAF
|
+$732K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.34M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.29M |
| 3 |
TWO
Two Harbors Investment
TWO
|
+$1.29M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$1.28M |
| 5 |
CERN
Cerner Corp
CERN
|
+$1.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.61% |
| 2 | Industrials | 15.51% |
| 3 | Financials | 14.29% |
| 4 | Technology | 14.02% |
| 5 | Healthcare | 12.51% |
Similar funds
Neo Ivy Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Neo Ivy Capital Management held 435 positions worth $86.5M, down 43% from $153M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
Neo Ivy Capital Management withdrew a net $70.6M in Q4 2019, closing 183 positions and reducing 63 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.29M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
Against the trend, Neo Ivy Capital Management opened a new position in MillerKnoll worth $678K.
- Neo Ivy Capital Management's largest Q4 2019 buy was MillerKnoll: 16,277 shares worth $678K.
- Neo Ivy Capital Management added most to CVS Health in Q4 2019, an estimated $657K increase.
- Neo Ivy Capital Management's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $1.34M.
- Neo Ivy Capital Management fully exited Alexion Pharmaceuticals in Q4 2019, selling an estimated $1.29M.
- Neo Ivy Capital Management's ten largest holdings make up 8.1% of its $86.5M portfolio in Q4 2019.
- Neo Ivy Capital Management opened 164 new positions and closed 183 in Q4 2019.
- Neo Ivy Capital Management's portfolio value fell 43% quarter-over-quarter to $86.5M.
Based on Neo Ivy Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.